ASX - By Stock
|
AVL |
Re:
Vanadium news
|
|
daon
|
6.3K |
2.8M |
2 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
6.3K
|
2.8M
|
2
|
|
ASX - By Stock
|
DGL |
Re:
Ann: FY23 Trading Update
|
|
daon
|
205 |
91K |
0 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
205
|
91K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
daon
|
2.6K |
1.0M |
0 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive Final Data in 2nd Line Metastatic NSCLC Patients
|
|
daon
|
7 |
4.6K |
4 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
7
|
4.6K
|
4
|
|
ASX - By Stock
|
GTR |
Re:
Ann: Rights Entitlement Issue Offer Document
|
|
daon
|
5 |
2.3K |
0 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
5
|
2.3K
|
0
|
|
ASX - By Stock
|
ALC |
Re:
Ann: Alcidion FY23 Appendix 4D and Half Year Report
|
|
daon
|
6 |
2.7K |
1 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
6
|
2.7K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
JPMorgan conference
|
|
daon
|
18 |
10K |
3 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
18
|
10K
|
3
|
|
ASX - By Stock
|
LRS |
Re:
Nearest to the pin by Xmas. Friday the 23rd of December No prize . Just bragging rights.
|
|
daon
|
164 |
84K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
164
|
84K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
daon
|
17 |
6.2K |
14 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
17
|
6.2K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial
|
|
daon
|
70 |
28K |
4 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
70
|
28K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Positive Response Rate In Phase II Trial In 1st Line NSCLC For PD-L1...
|
|
daon
|
23 |
12K |
3 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
23
|
12K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ASCO 2022 abstracts
|
|
daon
|
18 |
12K |
13 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
18
|
12K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to announce new TACTI-002 data at ASCO 2022
|
|
daon
|
47 |
28K |
1 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
47
|
28K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to announce new TACTI-002 data at ASCO 2022
|
|
daon
|
47 |
28K |
0 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
47
|
28K
|
0
|
|
ASX - By Stock
|
ERA |
Re:
Ann: Ranger Rehabilitation Project cost and schedule overruns
|
|
daon
|
16 |
9.1K |
1 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
16
|
9.1K
|
1
|
|
ASX - By Stock
|
AEF |
Re:
Ann: AEF Quarterly FUM & Flows
|
|
daon
|
12 |
9.4K |
0 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
12
|
9.4K
|
0
|
|
ASX - By Stock
|
AVL |
Re:
Ann: Letter of Intent for Iron Titanium Co-product Offtake Sales
|
|
daon
|
50 |
26K |
1 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
50
|
26K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ELCC 2022 abstract
|
|
daon
|
44 |
20K |
16 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
44
|
20K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ELCC 2022 abstract
|
|
daon
|
44 |
20K |
1 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ELCC 2022 abstract
|
|
daon
|
44 |
20K |
0 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
44
|
20K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ELCC 2022 abstract
|
|
daon
|
44 |
20K |
1 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ELCC 2022 abstract
|
|
daon
|
44 |
20K |
2 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
44
|
20K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ELCC 2022 abstract
|
|
daon
|
44 |
20K |
1 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Half Yearly Report and Accounts
|
|
daon
|
5 |
2.5K |
0 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
daon
|
2.6K |
1.0M |
0 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: First Regulatory Approval in Europe for DMX-200 FSGS Study
|
|
daon
|
10 |
4.1K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
10
|
4.1K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
daon
|
2.6K |
1.0M |
5 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze: TGA and Aust government negiligence
|
|
daon
|
116 |
26K |
1 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
116
|
26K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
$10 by Xmas 2021
|
|
daon
|
478 |
218K |
2 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
478
|
218K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
2 Green Day's surely not
|
|
daon
|
30 |
10K |
0 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
2 Green Day's surely not
|
|
daon
|
30 |
10K |
0 |
03/01/22 |
03/01/22 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
2 Green Day's surely not
|
|
daon
|
30 |
10K |
2 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
30
|
10K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Global Webcast Slides to Discuss Clinical Results
|
|
daon
|
22 |
9.7K |
0 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
22
|
9.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
daon
|
108 |
43K |
3 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
108
|
43K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
daon
|
108 |
43K |
3 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
108
|
43K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Definitive Proxy Statement
|
|
daon
|
22 |
7.1K |
0 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
22
|
7.1K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
daon
|
88 |
34K |
0 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
34K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
$10 by Xmas 2021
|
|
daon
|
478 |
218K |
2 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
478
|
218K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
$10 by Xmas 2021
|
|
daon
|
478 |
218K |
1 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
478
|
218K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives EMA scientific advice for Phase 3 in MBC
|
|
daon
|
24 |
9.1K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
24
|
9.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE ADMENTA agreement - supplementary information
|
|
daon
|
93 |
21K |
0 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
93
|
21K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Investor Briefing to be held 9 October at 9am
|
|
daon
|
37 |
17K |
0 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
37
|
17K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
$10 by Xmas 2021
|
|
daon
|
478 |
218K |
2 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
478
|
218K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Positive views on Starpharma
|
|
daon
|
66 |
15K |
1 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
66
|
15K
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
daon
|
30K |
15M |
1 |
24/08/21 |
24/08/21 |
Charts
|
30K
|
15M
|
1
|
|
ASX - By Stock
|
AVH |
Re:
$10 by Xmas 2021
|
|
daon
|
478 |
218K |
1 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
478
|
218K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
|
|
daon
|
246 |
135K |
5 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
246
|
135K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
daon
|
157 |
67K |
1 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
157
|
67K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep global webcast slides
|
|
daon
|
29 |
11K |
10 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
29
|
11K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble Lag-3 Protein, In...
|
|
daon
|
86 |
29K |
0 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
86
|
29K
|
0
|
|